Efficacy and Safety of Mirabegron in Men with Overactive Bladder Symptoms and Benign Prostatic Hyperplasia

被引：0
|
作者：
Gregory R. Mullen
Steven A. Kaplan
机构：
[1] Icahn School of Medicine at Mount Sinai,
来源：
Current Urology Reports | 2021年 / 22卷
关键词：
Urinary bladder; Overactive; Prostatic hyperplasia; Lower urinary tract symptoms; Mirabegron;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Beta 3 Adrenoreceptor Agonist for the Management of Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia: A Systematic Review
    Kang, Tae Wook
    Kim, Su Jin
    Kim, Myung Ha
    Jung, Jae Hung
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2021, 25 (03) : 182 - 191
  • [42] The efficacy and tolerability of the β3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients
    Wagg, Adrian
    Cardozo, Linda
    Nitti, Victor W.
    Castro-Diaz, David
    Auerbach, Stephen
    Blauwet, Mary Beth
    Siddiqui, Emad
    AGE AND AGEING, 2014, 43 (05) : 666 - 675
  • [43] The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis
    Lee, Sung Won
    Paick, Jae Seung
    Park, Hyun Jun
    Won, Ji Eon
    Morisaki, Yoji
    Sorsaburu, Sebastian
    Viktrup, Lars
    WORLD JOURNAL OF MENS HEALTH, 2014, 32 (01) : 28 - 35
  • [44] A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of persistent overactive bladder symptoms in men presenting with lower urinary tract symptoms (CONTACT Study)
    Yamanishi, Tomonori
    Kaga, Kanya
    Sakata, Koichi
    Yokoyama, Teruhiko
    Kageyama, Shinji
    Fuse, Miki
    Tokunaga, Shoji
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 (02) : 804 - 812
  • [45] Association of hypertension with symptoms of benign prostatic hyperplasia
    Michel, MC
    Heemann, U
    Schumacher, H
    Mehlburger, L
    Goepel, M
    JOURNAL OF UROLOGY, 2004, 172 (04) : 1390 - 1393
  • [46] Impact of benign prostatic hyperplasia surgical treatment on voiding and urinary bladder filling symptoms
    Milicevic, Snjezana
    Vasic, Dusko
    VOJNOSANITETSKI PREGLED, 2010, 67 (01) : 55 - 58
  • [47] Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia:a prospective study
    YANG Yong ZHAO Xiao-feng LI Han-zhong WANG Wei ZHANG Yong XIAO He ZHANG Xin Department of Urology
    中华医学杂志(英文版), 2007, (05) : 370 - 374
  • [48] Mirabegron in patients with Parkinson disease and overactive bladder symptoms: A retrospective cohort
    Peyronnet, Benoit
    Vurture, Gregory
    Palma, Jose-Alberto
    Malacarne, Dominique R.
    Feigin, Andrew
    Sussman, Rachael D.
    Biagioni, Milton C.
    Palmerola, Ricardo
    Gilbert, Rebecca
    Rosenblum, Nirit
    Frucht, Steven
    Kaufmann, Horacio
    Nitti, Victor W.
    Brucker, Benjamin M.
    PARKINSONISM & RELATED DISORDERS, 2018, 57 : 22 - 26
  • [49] Nerve Growth Factor Levels are Associated with Overactive Bladder Symptoms and Long-Term Treatment Outcome after Transurethral Resection of the Prostate in Patients with Benign Prostatic Hyperplasia
    Hu, Hao
    Zhang, Weiyu
    Liu, Xianhui
    Wang, Huanrui
    Fang, Zhiwei
    Liang, Chen
    Wang, Tao
    Xu, Kexin
    JOURNAL OF UROLOGY, 2018, 200 (03) : 620 - 625
  • [50] Efficacy and safety of combinations of mirabegron and solifenacin in patients with overactive bladder: a systematic review and meta-analysis
    Peng, Liao
    Zeng, Xiao
    Shen, Hong
    Luo, De-Yi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (02): : 1355 - 1365
12345